Should You Buy Allbirds Inc (BIRD) Today? Analysis, Price Targets, and 2026 Outlook.
Conclusion
Sell
Latest Price
3.980
1 Day change
0.25%
52 Week Range
12.850
Analysis Updated At
2026/01/28
BIRD is not a good buy right now for a beginner long-term investor with $50k–$100k who wants to deploy capital immediately. The trend is still bearish (major moving averages stacked bearishly), fundamentals are deteriorating (Q3 2025 revenue down 23% YoY with continued losses), and there are no near-term catalysts or supportive flow data (no notable hedge fund/insider/congress activity, no fresh news, no proprietary buy signals).
Technical Analysis
Trend is bearish: SMA_200 > SMA_20 > SMA_5 confirms a downtrend/weak structure. RSI(6)=33.06 is low but still labeled neutral here—suggesting weakness without a confirmed reversal. MACD histogram is slightly above 0 (0.00376) but positively contracting, which often signals fading upside momentum rather than a strong new uptrend. Price is near support: S1=3.881 and S2=3.737; a break below ~3.88 risks a move toward ~3.74. Key upside levels: pivot 4.114 then resistance at 4.347 and 4.491—stock would need to reclaim and hold above ~4.11 to argue for a durable trend change. Pattern-based projection also leans negative beyond the very short term: ~-1.88% next week and ~-4.27% next month.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Options data is sparse (many fields blank), but reported put/call ratios at 0.0 imply effectively no measured put activity relative to calls (or limited reporting/liquidity). Historical volatility is high (~71.18), which aligns with an unstable, higher-risk price profile rather than a steady long-term compounder. Overall, options do not provide a clear bullish confirmation signal here.
Technical Summary
Sell
9
Buy
2
Positive Catalysts
No positive catalysts identified in the provided dataset: no news in the last week, no proprietary buy signals (AI Stock Picker/SwingMax), and no notable hedge fund/insider accumulation trend reported.
Neutral/Negative Catalysts
Deteriorating business momentum (revenue down sharply YoY) with ongoing losses; bearish technical structure with price sitting close to support; lack of fresh news/catalysts to change sentiment; high volatility profile. Short-to-medium horizon statistical trend forecast is negative (next week/month).
Financial Performance
Latest quarter: 2025/Q3. Revenue fell to $32.99M (-23.27% YoY), indicating contracting demand/top-line pressure. Net income remained deeply negative at -$20.32M (down -4.03% YoY, i.e., slightly worse), and EPS was -2.49 (down -7.09% YoY), showing continued unprofitability. Gross margin was 43.17%, down 2.68% YoY—margin compression alongside revenue decline is a negative growth trend for a long-term investor.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating/price target change data was provided, so a recent trend cannot be confirmed. From the data available, the ‘Wall Street pro’ case is unclear; the ‘con’ case dominates: shrinking revenue, persistent losses, and a bearish chart with no clear reversal signal. Politician/congress activity: no recent congress trading data available; hedge fund and insider trends are reported as neutral.
Wall Street analysts forecast BIRD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BIRD is 14 USD with a low forecast of 14 USD and a high forecast of 14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast BIRD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BIRD is 14 USD with a low forecast of 14 USD and a high forecast of 14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 3.970
Low
14
Averages
14
High
14
Current: 3.970
Low
14
Averages
14
High
14
Morgan Stanley
Equal Weight
maintain
$5 -> $8
AI Analysis
2025-08-10
Reason
Morgan Stanley
Price Target
$5 -> $8
AI Analysis
2025-08-10
maintain
Equal Weight
Reason
Morgan Stanley raised the firm's price target on Allbirds to $8 from $5 and keeps an Equal Weight rating on the shares. The company reported a Q2 EBITDA beat on better than expected cost control and additional store closures, the analyst tells investors in a research note. The firm believes Allbirds' fundamentals remain challenged.
Morgan Stanley
Equal Weight
downgrade
$6 -> $5
2025-05-12
Reason
Morgan Stanley
Price Target
$6 -> $5
2025-05-12
downgrade
Equal Weight
Reason
Morgan Stanley lowered the firm's price target on Allbirds to $5 from $6 and keeps an Equal Weight rating on the shares. While management "has clearly made impressive progress on its strategic transformation plan," fundamentals remain highly challenged, the analyst tells investors following a "beat across-the-board" in Q1. Reiterated fiscal year guidance still assumes substantial second half improvement, which the firm call "potentially optimistic" given macro and tariff uncertainty as well as unproven new product success.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for BIRD
